| BioID | bio1864 |
| Name | ENCORAFENIB |
| ChEMBL ID | CHEMBL3301612 |
| Molecular Formula | C22H27ClFN7O4S |
| Molecular Weight | 540.02 |
| Molecular Weight (Monoisotopic) | 539.1518 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar11 |
| Target Name | Proto-oncogene c-RAF (c-RAF) |
| Synonyms | Braftovi|ENCORAFENIB|Encorafenib|LGX-818|LGX818|NVP-LGX-818-NXA|NVP-LGX818|NVP-LGX818-NXA |
| Smiles | COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1 |
| Inchi | InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1 |
| Inchi Key | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
| Molecular Species | NEUTRAL |
| Targets | 369.0 |
| Bioactivities | 401.0 |
| Np Likeness Score | -1.5 |
| Records Key | ['ENCORAFENIB', 'ENCORAFENIB', 'BDBM221688', 'ENCORAFENIB', 'ENCORAFENIB', 'ENCORAFENIB', 'LGX818', 'LGX818', 'Encorafenib', 'ENCORAFENIB', 'LGX818', '23', 'ENCORAFENIB', '9', 'LGX818', 'ENCORAFENIB', 'Encorafenib (LGX818)', 'EOS100618', 'encorafenib'] |
| Records Name | ['ENCORAFENIB', 'ENCORAFENIB', 'US9314464, 9', 'ENCORAFENIB', 'ENCORAFENIB', 'ENCORAFENIB', 'Encorafenib', 'Encorafenib', 'Encorafenib', 'ENCORAFENIB', 'LGX818', 'Encorafenib', 'ENCORAFENIB', 'Methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate', 'Encorafenib', 'ENCORAFENIB', 'Encorafenib (LGX818)', 'ENCORAFENIB', 'encorafenib'] |
| Withdrawn Flag | False |
| Orphan | 0 |